The impact of chronic in vivo glucocorticoid excess on the functional characteristics of human skin fibroblasts obtained from patients with endogenous Cushing's syndrome.

The impact of chronic in vivo glucocorticoid excess on the functional characteristics of human skin fibroblasts obtained from patients with endogenous Cushing's syndrome.

OBJECTIVE: Chronic exposure to elevated glucocorticoid (GC) concentrations induces detrimental effects in several tissues. In the skin, GCs provoke intense alterations on various parameters of the physiology of fibroblasts, cumulatively leading to skin atrophy and impaired wound healing. As there a...

Podrobná bibliografie
Hlavní autoři:	Zervolea, I, Pratsinis, H, Tsagarakis, S, Karavitaki, N, Stathakos, D, Thalassinos, N, Kletsas, D
Médium:	Journal article
Jazyk:	English
Vydáno:	2005

Podobné jednotky

The Unexpected Anabolic Phenotype and Extended Longevity of Skin Fibroblasts after Chronic Glucocorticoid Excess
Autor: Harris Pratsinis, a další
Vydáno: (2006-04-01)

Assessment of GH reserve before and after successful treatment of adult patients with Cushing's syndrome.
Autor: Tzanela, M, a další
Vydáno: (2004)

Evaluation of bone mineral density of the peripheral skeleton in pre- and postmenopausal women with newly diagnosed endogenous Cushing's syndrome.
Autor: Karavitaki, N, a další
Vydáno: (2004)

Evaluation of GH reserve in patients with adrenal incidentalomas and biochemical evidence of subclinical autonomous glucocorticoid hypersecretion.
Autor: Tzanela, M, a další
Vydáno: (2005)

Coexistence of bone and vascular disturbances in patients with endogenous glucocorticoid excess
Autor: Chieko Yano, a další
Vydáno: (2022-12-01)

Metformin and Bone Metabolism in Endogenous Glucocorticoid Excess: An Exploratory Study
Autor: Frederick Vogel, a další
Vydáno: (2021-10-01)

E47 as a novel glucocorticoid-dependent gene mediating lipid metabolism in patients with endogenous glucocorticoid excess
Autor: Wei Zhang, a další
Vydáno: (2023-11-01)

Mortality in Cushing's syndrome: systematic analysis of a large series with prolonged follow-up.
Autor: Ntali, G, a další
Vydáno: (2013)

Challenges in the postsurgical recovery of cushing syndrome: glucocorticoid withdrawal syndrome
Autor: Catherine D. Zhang, a další
Vydáno: (2024-04-01)

Glucocorticoid-induced osteoporosis: lessons from Cushing's syndrome.
Autor: Tóth, M, a další
Vydáno: (2013)

Invasive fungal infections in endogenous Cushing’s syndrome
Autor: Rafael Selbach Scheffel, a další
Vydáno: (2010-06-01)

Etomidate in the management of hypercortisolaemia in Cushing's syndrome: a review.
Autor: Preda, V, a další
Vydáno: (2012)

Metabolic complications of endogenous Cushing: patient selection for screening
Vydáno: (2013-03-01)

Activation of the JNKs/ATM-p53 axis is indispensable for the cytoprotection of dermal fibroblasts exposed to UVB radiation
Autor: Eleni Mavrogonatou, a další
Vydáno: (2022-07-01)

Cushing’s glucocorticoid syndrome in the practice of a rheumatologist (A review of literature)
Autor: Azamat Makhmudovich Satybaldyev
Vydáno: (2013-12-01)

The Effect of Chronic Glucocorticoid Exposure on Brown Adipose Tissue in Cushing’s Disease
Autor: Alev Selek, a další
Vydáno: (2021-03-01)

Cushing’s syndrome with no clinical stigmata – a variant of glucocorticoid resistance syndrome
Autor: Ved V. Gossain, a další
Vydáno: (2018-12-01)

Disturbed bone marrow adiposity in patients with Cushing’s syndrome and glucocorticoid- and postmenopausal- induced osteoporosis
Autor: Nina N. Sørensen, a další
Vydáno: (2023-10-01)

The Regulation of Muscle Mass by Endogenous Glucocorticoids
Autor: Daniel L Marks, a další
Vydáno: (2015-02-01)

Co-Occurrence of Exogenous and Endogenous Cushing’s Syndromes—Dilemma in Diagnosis
Autor: Chin Voon Tong, a další
Vydáno: (2019-01-01)

Endogenous Obesity Associated with Cushing’s Disease: A Case Report
Autor: Müge Şahin, a další
Vydáno: (2021-03-01)

Role of endogenous glucocorticoids in hyperalgesia and edema in old arthritic rats
Autor: C.M. Yokoro, a další
Vydáno: (2003-01-01)

An N-ethyl-N-nitrosourea induced corticotropin-releasing hormone promoter mutation provides a mouse model for endogenous glucocorticoid excess.
Autor: Bentley, L, a další
Vydáno: (2014)

An N-ethyl-n-nitrosourea induced corticotropin-releasing hormone promoter mutation provides a mouse model for endogenous glucocorticoid excess
Autor: Bentley, L, a další
Vydáno: (2014)

Modern Treatment of Cushing's Shows a High Cure Rate and a Low Mortality.
Autor: Ntali, G, a další
Vydáno: (2010)

Decreased Trabecular Bone Score in Patients With Active Endogenous Cushing’s Syndrome
Autor: Barbara Stachowska, a další
Vydáno: (2021-01-01)

Exogenous Cushing Syndrome: When do We Get the Benefit of Glucocorticoid Stress Dose?
Autor: Soebagijo Adi Soelistijo, a další
Vydáno: (2020-09-01)

The Impact of Environmental and Endogenous Damage on Somatic Mutation Load in Human Skin Fibroblasts.
Autor: Natalie Saini, a další
Vydáno: (2016-10-01)

Choroidal thickness and retinal abnormalities by optical coherence tomography in endogenous Cushing’s syndrome
Autor: Maria Fernanda Abalem, a další
Vydáno: (2016-12-01)

Adrenal Insufficiency under Standard Dosage of Glucocorticoid Replacement after Unilateral Adrenalectomy for Cushing’s Syndrome
Autor: Kentaro Fujii, a další
Vydáno: (2016-01-01)

The expression of glucocorticoid and mineralocorticoid receptors in pituitary tumors causing Cushing’s disease and silent corticotroph tumors
Autor: Paulina Kober, a další
Vydáno: (2023-03-01)

Clinical Characteristics of Endogenous Cushing’s Syndrome at a Medical Center in Southern Taiwan
Autor: Shih-Chen Tung, a další
Vydáno: (2013-01-01)

Endogenous glucocorticoids in inflammation: contributions of systemic and local responses
Autor: Rowan S. Hardy, a další
Vydáno: (2012-07-01)

Optogenetic elevation of endogenous glucocorticoid level in larval zebrafish
Autor: Rodrigo J De Marco, a další
Vydáno: (2013-05-01)

Neurocognitive functions and brain volume in patients with endogenous cushing's syndrome before and after curative surgery
Autor: Nachimuthu Kumar, a další
Vydáno: (2020-01-01)

AMP-activated protein kinase mediates glucocorticoid-induced metabolic changes: a novel mechanism in Cushing's syndrome.
Autor: Christ-Crain, M, a další
Vydáno: (2008)

Design and Synthesis of Novel Antioxidant 2-Substituted-5,7,8-Trimethyl-1,4-Benzoxazine Hybrids: Effects on Young and Senescent Fibroblasts
Autor: Theano Fotopoulou, a další
Vydáno: (2024-06-01)

Therapy in endocrine disease: Etomidate in the management of hypercortisolaemia in Cushing's syndrome: A review (European Journal of Endocrinology 167, (137-143))
Autor: Preda, V, a další
Vydáno: (2013)

Different Potent Glucocorticoids, Different Routes of Exposure but the Same Result: Iatrogenic Cushing’s Syndrome and Adrenal Insufficiency
Autor: Ayla Güven
Vydáno: (2020-12-01)

Holistic burden of illness in patients with endogenous Cushing's syndrome: A systematic literature review
Autor: Gabrielle Page‐Wilson, a další
Vydáno: (2024-01-01)